Your session is about to expire
← Back to Search
Other
Hyperbaric Oxygen Therapy (HBOT) for Coronavirus
N/A
Waitlist Available
Led By Enoch Huang, MD
Research Sponsored by Legacy Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial suggests that hyperbaric oxygen therapy may help reduce mortality or the need for mechanical ventilation for COVID-19 patients.
Eligible Conditions
- Coronavirus
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of 60-Day Patient Mortality
Secondary outcome measures
Number of Participants Displaying Presence of Any Pulmonary Function Abnormality
Number of Patients with Ongoing Clinical Symptoms
Time to Mechanical Ventilation
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Hyperbaric OxygenExperimental Treatment1 Intervention
Hyperbaric Oxygen Therapy (HBOT) + Standard of Care (SOC) as defined by current best practice treatments for COVID-19
Group II: Standard of CareActive Control1 Intervention
Standard of Care (SOC) as defined by current best practice treatments for COVID-19
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hyperbaric Oxygen Therapy (HBOT)
2008
N/A
~170
Find a Location
Who is running the clinical trial?
Legacy Health SystemLead Sponsor
35 Previous Clinical Trials
3,654 Total Patients Enrolled
Enoch Huang, MD5.02 ReviewsPrincipal Investigator - Legacy Research Institute
Legacy Health System
2 Previous Clinical Trials
25 Total Patients Enrolled
5Patient Review
Dr. Huang is an excellent doctor. He is very honest and open with me about my health, and he is very responsive to my needs.
Share this study with friends
Copy Link
Messenger